Marshall Wace’s Protara Therapeutics TARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$264K Sell
50,731
-533,797
-91% -$3.16M ﹤0.01% 2694
2025
Q4
$3.12M Buy
584,528
+298,942
+105% +$1.66M ﹤0.01% 1370
2025
Q3
$1.24M Sell
285,586
-76,940
-21% -$249K ﹤0.01% 1850
2025
Q2
$1.1M Buy
+362,526
New +$1.25M ﹤0.01% 1807
2024
Q4
Sell
-77,351
Closed -$142K 3025
2024
Q3
$142K Hold
77,351
﹤0.01% 2338
2024
Q2
$161K Buy
+77,351
New +$226K ﹤0.01% 2340
2021
Q4
Sell
-15,190
Closed -$105K 4346
2021
Q3
$105K Sell
15,190
-2,279
-13% -$17.8K ﹤0.01% 2885
2021
Q2
$170K Sell
17,469
-24,667
-59% -$279K ﹤0.01% 2477
2021
Q1
$664K Buy
+42,136
New +$781K ﹤0.01% 1824

Other funds holding TARA